Skip to main content
OpenTrials

Clinical trial condition

Gastroesophageal Reflux

Explore clinical trials studying Gastroesophageal Reflux. Study availability and eligibility vary by location and protocol.

853 public trials 103 recruiting studies
Refine in advanced search Browse all conditions

Gastroesophageal Reflux trial results

Completed

Efficacy of Pantoprazole 20/40 mg Once Daily (od) in Patients Older Than 12 Years Who Have Gastrointestinal Symptoms of Reflux Disease

NCT00829738

Conditions
Deglutition Disorders, Digestive System Diseases, Esophageal Diseases, +4 more
Locations
  • Nycomed Deutschland GmbH Aachen, Germany
  • Nycomed Deutschland GmbH Aachen, Germany
  • Nycomed Deutschland GmbH Ahrensburg, Germany
  • Nycomed Deutschland GmbH Alpenrod, Germany
View all 717 locations
View Trial Details
Completed

Pantoprazole 20/40 mg in the Treatment of Symptomatic Reflux Disease With Focus on Sleep Disorders

NCT00830115

Conditions
Deglutition Disorders, Digestive System Diseases, Esophageal Diseases, +13 more
Locations
  • Nycomed Deutschland GmbH Aachen, Germany
  • Nycomed Deutschland GmbH Ahrensburg, Germany
  • Nycomed Deutschland GmbH Altenburg, Germany
  • Nycomed Deutschland GmbH Ansbach, Germany
View all 201 locations
View Trial Details
Completed

Efficacy of Pantoprazole in Patients Older Than 12 Years Who Have Symptoms of Non-Erosive Reflux Disease (NERD) or Erosive Gastroesophageal Reflux Disease (eGERD)

NCT00561730

Conditions
Deglutition Disorders, Digestive System Diseases, Esophageal Diseases, +5 more
Locations
  • Nycomed Deutschland GmbH Aachen, Germany
  • Nycomed Deutschland GmbH Ahrensburg, Germany
  • Nycomed Deutschland GmbH Alfeld, Germany
  • Nycomed Deutschland GmbH Altenburg, Germany
View all 259 locations
View Trial Details
Completed

Determination of the Minimal Clinically Important Difference After Treatment With Pantoprazole in Patients With Symptoms of Acid Reflux (Gastroesophageal Reflux Disease) (BY1023/M3-340)

NCT00246909

Conditions
Deglutition Disorders, Digestive System Diseases, Esophageal Diseases, +3 more
Locations
  • Altana Pharma/Nycomed Alabaster, Alabama, United States
  • Altana Pharma/Nycomed Huntsville, Alabama, United States
  • Altana Pharma/Nycomed Mesa, Arizona, United States
  • Altana Pharma/Nycomed Tucson, Arizona, United States
View all 51 locations
View Trial Details
Completed

Efficacy of Pantoprazole in Patients Older Than 18 Years Who Have Symptoms of Non-erosive Reflux or Gastroesophageal Reflux Disease (BY1023/DE-004)

NCT00326027

Conditions
Deglutition Disorders, Digestive System Diseases, Esophageal Diseases, +3 more
Locations
  • Nycomed Deutschland GmbH Augsburg, Germany
  • Nycomed Deutschland GmbH Berlin, Germany
  • Nycomed Deutschland GmbH Brandenburg, Germany
  • Nycomed Deutschland GmbH Cologne, Germany
View all 35 locations
View Trial Details
Completed

Determination of a Questionnaire After Treatment With Pantoprazole at Full Dose and Half Dose in Adult Patients With Symptoms of Acid Reflux (Gastroesophageal Reflux Disease) (BY1023/UK-506)

NCT00261339

Conditions
Deglutition Disorders, Digestive System Diseases, Esophageal Diseases, +5 more
Locations
  • Altana Pharma/Nycomed Antrim, United Kingdom
  • Altana Pharma/Nycomed Ashford, United Kingdom
  • Altana Pharma/Nycomed Aston Clinton, Aylesbury, United Kingdom
  • Altana Pharma/Nycomed Atherstone, Warwick, United Kingdom
View all 45 locations
View Trial Details
Completed

Comparison of the Classical Healing Concept With the Complete Remission Concept After Treatment With Pantoprazole in Adult Patients With Erosive GERD (Gastroesophageal Reflux Disease) (BY1023/M3-342)

NCT00325676

Conditions
Deglutition Disorders, Digestive System Diseases, Disease Attributes, +9 more
Locations
  • Altana Pharma/Nycomed Belo Horizonte-MG, Brazil
  • Altana Pharma/Nycomed Blumenau - SC, Brazil
  • Altana Pharma/Nycomed Botucatu - SP, Brazil
  • Altana Pharma/Nycomed Campinas - Sao Paulo, Brazil
View all 45 locations
View Trial Details
Completed

Symptom Assessment in Adult Patients With Erosive GERD (Gastroesophageal Reflux Disease) or enGERD (Endoscopic-negative GERD) After Treatment With Pantoprazole (BY1023/M3-343)

NCT00336219

Conditions
Deglutition Disorders, Digestive System Diseases, Esophageal Diseases, +4 more
Locations
  • Altana Pharma/Nycomed Bondi Junction, Australia
  • Altana Pharma/Nycomed Box Hill, Victoria, Australia
  • Altana Pharma/Nycomed New South Wales, Australia
  • Altana Pharma/Nycomed South Australia, Australia
View all 40 locations
View Trial Details
Completed

Efficacy of Pantoprazole in Patients Older Than 18 Years Who Have Symptoms of Acid Reflux (Gastroesophageal Reflux Disease) (BY1023/M3-339)

NCT00163306

Conditions
Deglutition Disorders, Digestive System Diseases, Esophageal Diseases, +3 more
Locations
  • Altana Pharma/Nycomed Deutschlandsberg, Austria
  • Altana Pharma/Nycomed Feldbach, Austria
  • Altana Pharma/Nycomed Graz, Austria
  • Altana Pharma/Nycomed Graz, Austria
View all 79 locations
View Trial Details
Completed

Effect of Pantoprazole on the Symptoms of Acid Reflux Disease in Adult Patients (BY1023/M3-341)

NCT00312806

Conditions
Deglutition Disorders, Digestive System Diseases, Esophageal Diseases, +4 more
Locations
  • Altana Pharma/Nycomed Buenos Aires, Argentina
  • Altana Pharma/Nycomed Buenos Aires, Argentina
  • Altana Pharma/Nycomed Buenos Aires, Argentina
  • Altana Pharma/Nycomed La Plata, Argentina
View all 186 locations
View Trial Details

Related conditions